R40C (p.Arg40Cys) variant of JAK3 (Tyrosine-protein kinase JAK3)

R40C (p.Arg40Cys) in JAK3 (Tyrosine-protein kinase JAK3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.17 / 1. The record also includes population frequency data and structural context.

R40C (p.Arg40Cys) variant details